espen congress the hague 2017 · a.2. inadequate nutritional intake is common, and patient factors...
TRANSCRIPT
ESPEN Congress The Hague 2017Upcoming ESPEN Guidelines
Polymorbid internal medicine inpatients guidelines
F. Gomes (CH)
ESPEN guidelines on nutritional support for
polymorbid internal medicine patients
Filomena Gomes, RD PhD
(on behalf of the Working Group)
Filomena Gomes & Philipp
Schuetz (CH) - coordinators
Lisa Bounoure (CH)
Peter Austin (UK)
María Ballesteros-Pomar (ES)
Tommy Cederholm (SE)
Jane Fletcher (UK)
Alessandro Laviano (IT)
Kristina Norman (DE)
Kalliopi-Anna Poulia (EL)
Paula Ravasco (PT)
Stephane M. Schneider (FR)
Zeno Stanga (CH)
C. Elizabeth Weekes (UK)
Stephan C. Bischoff (DE)
Working group
2
3
Shareholder No relevant conflicts of interest to declare
Grant / Research Support No relevant conflicts of interest to declare
Consultant No relevant conflicts of interest to declare
Employee No relevant conflicts of interest to declare
Paid Instructor No relevant conflicts of interest to declare
Speaker bureau No relevant conflicts of interest to declare
Other No relevant conflicts of interest to declare
Introduction
Polymorbidity (AKA multimorbidity):
• co-occurrence of at least two chronic health conditions in the same person (Lefèvre, 2014; WHO, 2008, Marengoni, 2011)
• > 70% of the hospitalized adult population, associated with higher mortality and healthcare burden (Steiner, 2014)
• prevalence increases with age, but > 50% people affected with this problem are < 65 years (Barnett, 2011)
• clinical guidelines mainly created for single diseases pt with multiple conditions?
4
5
Guidelines for
polymorbid
patients!
6
MethodsPragmatic definition of polymorbidity (individual vs. study
population):
• at least 2 co-occurring chronic diseases present in at least 50% of
the study population
• a Charlson comorbidity index or mean number of diseases or
drugs (medications) > 1.5
• In case of uncertainties, study authors were contacted if not
reached, consensus decision within the WG
Example of an included study (Norman, 2011) - mean number of chronic
diseases/patient and drugs/patient in each group was:
IG - 5 chronic illness/patient and 5 drugs/pt
CG - 4.6 chronic illness/patient and 3.9 drugs/pt 7
Inclusion/exclusion criteriaCriteria Inclusion Exclusion
Pa
tie
nts
ch
ara
cte
risti
cs
Human adults aged ≥ 18 years Non human, < 18 years, pregnant women
Patients hospitalized in acute care wards
Pt in critical/intensive care units, surgical patients
Pt living in long-term care facilities; outpatients
Pt receiving end of life care
- Polymorbid inpatients population as defined by:
a) at least 2 co-occurring chronic diseases present in at least
50% of the study population
b) mean number of diseases or drugs/medication or
Charlson comorbidity index > 1.5
If in doubt, authors contacted; if no reply, WG consensus
decision about inclusion/exclusion
Healthy population
Less than 50% of the study population has 2 co-
occurring diseases
Outcomes
Nutritional outcomes (e.g. weight, energy and protein intake)
Clinical outcomes (e.g. mortality, infections)
Patient-centred outcomes (e.g. quality of life)
Healthcare resources
Language
and yearEnglish; no restriction on publication year
8
Methodology (SOP for ESPEN guidelines):
• initial meeting (Jan 2016) to define clinical questions (PICO), inclusion/exclusion crietria, search terms
• systematic literature search (1 single author) in secondary sources & primary sources (Medline, Embase and the Cochrane Library), until April 2016
• literature selection quality assessment assignment of level of evidence for included papers draft of recommendation grade of recommendation
• online voting (Feb 2017) final consensus conference (Apr 2017)
9
10
Clinical
questions
E + P
requirements
Monitoring
Indication
Micronutrient
requirements
Route of
feeding
Timing
Procedure of
intervention
Disease-
specific
nutrients
11
TimingUse of
specific
nutrients
Polymorbid
medical
inpatient
population?
Results
Number of abstracts retrieved in
Included
studiesMedline EmbaseCochrane
LibraryTotal
Question 1 369 737 381 1401 2
Question 2 188 267 183 404 11
Question 3 318 532 327 859 1
Question 4 114 156 26 189 1
Question 5 162 220 82 395 2
Question 6 3 8 2 13 0
Question 7 116 174 102 223 2
Question 8 349 462 282 598 2
Question 9 6 4 10 19 10
Question 10 61 95 141 260 2
Question 11 18 23 7 25 2
Question 12 89 93 28 146 3
12 clinical questions
4532 retrieved
abstracts
38 included studies
22 recommendations
4 statements
12
Online voting and levels of agreement
• strong consensus (agreement of >90%) in 68% of recommendations
and 75% of statements
• consensus (agreement of >75-90%) in 32% of recommendations and
25% of statements
• no recommendations or statements reached an agreement < 75%
feedback from online voting used to modify and improve
recommendations in order to reach a higher degree of acceptance at
the final consensus meeting recommendations and statements with
< 90% agreement were discussed second voting: consensus >
89% was reached for all of the recommendations. 13
Summary of clinical questions and recommendations
Topic Clinical question and recommendation(s)/ statement(s)
Ind
ica
tio
n 1. Nutritional support based on screening and/or assessment vs. no screening and/or assessment
1.1. A quick and simple nutritional screening method using different validated tools should be applied to identify
malnutrition risk. In patients at risk, a more detailed assessment should be performed and a treatment plan should be
developed (….)
(Grade of recommendation (GR) B - strong consensus)
Ro
ute
of
fee
din
g
2. In malnourished polymorbid inpatients or those at high risk of malnutrition whose nutritional requirements
can be met orally: oral nutritional supplements (ONS), +/- nutritional counseling, vs. no ONS?
2.1. ONS high in energy and protein shall be considered to improve their nutritional status and quality of life.
(GR A - strong consensus)
2.2. Nutrient-specific ONS should be administered, when they may maintain muscle mass, reduce mortality or improve
quality of life
(GR B - consensus)
2.3. ONS should be considered as a cost-effective way of intervention towards improved outcomes
(GR B - strong consensus)
3. In pt where nutritional requirements cannot be met orally: enteral nutrition (EN) vs. parenteral nutrition (PN)
(total or supplemental)?
3.1. EN can be administered and may be superior to PN because of a lower risk of infectious and non-infectious
complications.
(GR 0 - strong consensus) 14
En
erg
y r
eq
uir
em
en
ts
4. Estimation of energy requirements with a prediction equation vs. a weight-based formula in pt
requiring nutritional support
4.1. Energy requirements can be estimated using indirect calorimetry (IC), a published prediction equation or a
weight-based formula.
(GR 0 - strong consensus)
4.2 In the absence of IC, total energy expenditure (TEE) for polymorbid older patients (aged > 65 years) can be
estimated using the formula 27 kcal/kg actual body weight (BW). Resting energy expenditure (REE) can be
estimated using the formula 18 - 20 kcal/kg BW with the addition of activity or stress factors to estimate TEE.
(GR 0 - strong consensus)
4.3.a In the absence of IC, REE for severely underweight patients can be estimated using the formula 30 kcal/kg
BW.
(GR 0 - consensus)
4.3.b. This target of 30 kcal/kg BW in severely underweight patients should be cautiously and slowly achieved, as
this is a population at high risk of refeeding syndrome.
(GR GPP - strong consensus)
Pro
tein
req
uir
em
en
ts
5. Protein targets higher than 1.0g/kg BW/day vs. a lower target in patients requiring nutritional support
5.1. Pt shall receive a minimum of 1.0 g of protein/kg BW/day in order to prevent body weight loss, reduce the risk
of complications and hospital readmission and improve functional outcome.
(GR A - strong consensus)
15
Mic
ron
utr
ien
ts
req
uir
em
en
ts
6. In pt exclusively fed orally: supplementation of micronutrients (vitamins and trace
elements) vs. no supplementation
6.1. Adequate intake of micronutrients (vitamins and trace elements) to meet daily estimated
requirements should be ensured.
(GR GPP - strong consensus)
6.2. Pt with documented or suspected micronutrient deficiencies should be repleted.
(GR GPP - strong consensus)
Dis
ea
se-s
pecif
ic n
utr
ien
ts
7. Disease-specific nutritional supplementation (e.g. fibre, omega 3 fatty acids, BCAA,
glutamine, etc.) vs. standard formulations
7.1. In pt with pressure ulcers, specific amino-acids (arginine and glutamine) and β-hydroxy β-
methylbutyrate (ßHMB) can be added to oral/enteral feeds to accelerate the healing of pressure
ulcers.
(GR 0 - consensus)
7.2. In older pt requiring enteral nutrition, formulas enriched in a mixture of soluble and insoluble
fibers can be used to improve bowel function.
(GR 0 - strong consensus)
16
Tim
ing
8. Early nutritional support (i.e. provided less than 48h post hospital admission) vs. later nutritional support
8.1. Early nutritional support should be performed, as sarcopenia could be decreased and self-sufficiency could be
improved
(GR B - strong consensus)
9. Continued use of nutritional support after discharge vs. during inpatient stay alone
9.1. In malnourished pt/at risk of malnutrition, nutritional support shall be continued after hospital discharge in order
to maintain or improve body weight and nutritional status.
(GR A - strong consensus)
9.2. In malnourished pt/at risk of malnutrition, nutritional support should be continued post hospital discharge to
maintain or improve functional status and quality of life.
(GR B - strong consensus)
9.3. In malnourished pt/at risk of malnutrition aged 65 and older, continued nutritional support post hospital discharge
with either ONS or individualized nutritional intervention shall be considered to lower mortality.
(GR A - strong consensus)
17
Mo
nit
ori
ng
10. Monitoring of physical functions, when possible, vs. monitoring of nutritional parameters (e.g. body
weight, energy and protein intakes)
10.1. Nutritional parameters should be monitored to assess responses to nutritional support, while functional indices
should be used to asses other clinical outcomes (i.e., survival, quality of life)
(GR B - strong consensus)
11. Meeting >75% of energy and/or protein requirements (as an indicator of compliance) vs. lower %
11.1. In pt with reduced food intake and hampered nutritional status, at least 75% of calculated energy and protein
requirements should be achieved in order to reduce the risk of adverse outcomes.
(GR B - strong consensus)
11.2. Energy and protein fortified foods can be used in order to reach those relevant energy and protein targets in
polymorbid medical inpatients.
(GR 0 - strong consensus)
Pro
ce
du
re o
f
inte
rve
nti
on
12. Organizational changes in nutritional support (e.g. intervention of a steering committee, implementation
of protected mealtimes, different budget allocation) vs. no changes
12.1. Organizational changes in nutritional support provision should be implemented for pt malnourished/at risk of
malnutrition. In particular, interventions that ensure the provision of fortified menus, establishing a nutrition support
team and the use of multi-disciplinary nutrition protocols should be implemented.
(GR B - strong consensus )
18
No
n-P
ICO
qu
es
tio
ns
a) Does underlying disease have an impact on expected outcome from nutritional support?
a.1. The severity of acute-phase response may be used by clinicians as part of the criteria for selecting patients for
nutritional screening, follow-up, and intervention.
(Level of Evidence (LE) 1+; strong consensus)
a.2. Inadequate nutritional intake is common, and patient factors contributing to poor intake should be considered
in designing nutritional interventions. (…) Poor intake is associated with several common patient/environmental
characteristics, e.g. disease severity, anorexia, bedridden, hospital routines, therapeutic diets, etc.
(LE 4 - strong consensus)
b) How long should nutritional support be given in order to have an impact on the clinical course?
b. Although there is evidence to recommend the continued nutritional support post-hospital discharge on
malnourished pt/at risk of malnutrition, the ideal duration of the intervention has not yet been determined.
(LE4; strong consensus)
c) Are there risks of polypharmacy and drug-nutrient interaction (in polymorbid pt)?
c. There is an important possibility of drug-drug or drug-nutrient interactions that needs to be taken into account,
by establishing a pharmacist-assisted management plan for any interactions.
(LE3; consensus)19
Statements
Discussion
• Major challenge: is the study population polymorbid?
- Cannot use search terms for polymorbidity large number of abstracts
- Need to obtain and read full paper (+ contact author)
• Future: encourage authors of future trials to report data on multiple comorbidities + use it as key words
• Other challenges: unavoidable overlap
with other disease-specific guidelines20
• Despite the methodological difficulties, we reviewed the
evidence behind several important aspects of nutritional
support for polymorbid medical inpatients, from
screening until post-discharge, including drug-nutrient
interactions
• Complex needs of this population access to dietetic
expertise to assess, manage and monitor nutritional status
and nutritional intervention
• Community-based approaches (at nutritional risk
population) prevention and early intervention21
• Evidence is still limited in several areas need of larger,
well conducted RCTs in this population, e.g. EFFORT trial
22
Bounoure & Gomes et al, Nutrition 32 (2016) 790–798
References• Lefèvre T, d’Ivernois JF, De Andrade V, Crozet C, Lombrail P, Gagnayre R. What do we mean by multimorbidity? An
analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization.
Revue d'Épidémiologie et de Santé Publique. 2014;62(5):305-14.
• World Health Organization. The World Health Report 2008: primary health care (now more than ever). World Health
Organization 2008.
• Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic
review of the literature. Ageing Research Reviews. 2011;10(4):430-9
• Steiner CA, Friedman B. Hospital utilization, costs, and mortality for adults with multiple chronic conditions, Nationwide
Inpatient Sample, 2009. Preventing chronic disease. 2013;10.
• Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for
health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37-43.
• Bischoff SC, Singer P, Koller M, Barazzoni R, Cederholm T, van Gossum A. Standard operating procedures for ESPEN
guidelines and consensus papers. Clin Nutr 2015;34:1043e51.
• Norman K, Pirlich M, Smoliner C, Kilbert A, Schulzke JD, Ockenga J, et al. Cost effectiveness
of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot
study. Eur J Clin Nutr 2011;65:735e42.
• Bounoure L, Gomes F, Stanga Z, Keller U, Meier R, Ballmer P, et al. Detection and treatment of medical inpatients with
or at-risk of malnutrition: suggested procedures based on validated guidelines. Nutrition 2016;32:790e8.
23
Question Title of the included study Author, Publication year Evidence of polymorbidityLevel of
evidence
1Cost-effectiveness of an interdisciplinary intervention in geriatric
inpatients to prevent malnutritionRypkema, 2013
Agreeement within working group, following attempt to contact author
2+
1Impact of nutritional support on clinical outcome in patients at
nutritional risk: A multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals
Jie, 2010Agreeement within working group, following attempt to contact author
2+
2Early nutritional support and physiotherapy improved long-term
self-sufficiency in acutely ill older patientsHegerová, 2015 Confirmed by author 1++
2Dietary supplementation and quality of life of older patients: a
randomized, double-blind, placebo-controlled trialGariballa, 2007
Mean number of chronic diseases and drugs: 1.7 and 3.5 in the control group,
respectively; 1.9 and 3.5 in the intervention group, respectively
1++
2Effects of dietary supplements on depressive symptoms in older
patients: a randomised double-blind placebo-controlled trialGariballa, 2007 b)
Mean number of chronic diseases and drugs: 1.7 and 3.5 in the control group,
respectively; 1.9 and 3.5 in the intervention group, respectively
1++
2A randomized, double-blind, placebo-controlled trial of
nutritional supplementation during acute illnessGariballa, 2006
Mean number of chronic diseases and drugs: 1.7 and 3.5 in the control group,
respectively; 1.9 and 3.5 the intervention group, respectively
1++
2Protein energy malnutrition in severe alcoholic hepatitis:
diagnosis and response to treatmentMendenhall, 1995
> 2 co-occurring chronic diseases in > 50% of the study population
1-
2Short-term individual nutritional care as part of routine clinical setting improves outcome and quality of life in malnourished
medical patientsStarke, 2011
Mean number of drugs: 7 in the control group, 6 the intervention group
1++
2Nutritional support and functional status in undernourished
geriatric patients during hospitalization and 6-month follow-up.Volkert, 1996
Reported in the paper: "All patients suffered from multiple diseases (...). The mean number of prescribed drugs was
2.4".
2+
2Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A
randomized clinical trial Deutz, 2016
Mean Charlson comorbidity index: 2.05 in the control group, 2.12 in the
intervention group. 1++
2Impact of Oral Nutritional Supplementation on Hospital
OutcomesPhilipson, 2003 Mean Charlson comorbidity index: 3.5 2++
2Protein Energy Supplements in Unwell Elderly Patients - A
Randomized Controlled TrialPotter, 2001
Agreeement within working group, following attempt to contact author
2++
2Routine oral nutritional supplementation for stroke patients in
hospital (FOOD): a multicentre randomised controlled trial.Dennis, 2005
Agreeement within working group, following attempt to contact author
1++
3Impact of nutritional support on clinical outcome in patients at
nutritional risk: A multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals
Jie, 2010Agreeement within working group, following attempt to contact author
2+
4Energy requirements in frail elderly people: A review of the
literatureGaillard 2007
Some included studies described patients as polymorbid
2++
5Short-term individual nutritional care as part of routine clinical setting improves outcome and quality of life in malnourished
medical patientsStarke, 2011
Mean number of drugs: 7 in the control group, 6 in the intervention group
1++
5Protein is an important component of nutritional support
predicting complications in malnourished hospitalised patients details of our previous randomised controlled trial (RCT)
Drommer, 2015Mean number of drugs: 7 in the control
group, 6 in the intervention group1++
7The use of a specialised amino acid mixture for pressure ulcers: a
placebo-controlled trial. Wong, 2014 Confirmed by author 1+
7 Fibre-supplemented tube feeding in the hospitalised elderly Vandewoude, 2005 Confirmed by author 1++
8Early nutritional support and physiotherapy improved long-term
self-sufficiency in acutely ill older patientsHegerová, 2015 Confirmed by author 1+
8Impact of early enteral nutrition on short term prognosis after
acute strokeZheng, 2015
> 2 co-occurring chronic diseases in > 50% of the study population
1-
24
9Prevention of malnutrition in older people during
and after hospitalisation: results from a randomised controlled clinical trial
Gazzotti, 2003Mean number of drugs: 5.8 in the control group, 5.5 in the
intervention group1++
9
Three month intervention with protein and energy rich supplements improve muscle function and
quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized
controlled trial
Norman, 2008 Mean number of drugs: 6 in the
control group, 4 in the intervention group
1+
9Cost-effectiveness of a 3-month intervention with
oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study.
Norman, 2011
Mean number of chronic diseases and drugs: 4.6 and 3.9
in the control group, respectively; 5 and 5 in the
intervention group, respectively
1+
9Individualized nutritional intervention during and
after hospitalization: the nutrition intervention study clinical trial
Feldblum, 2011
Mean Charlson comorbidity index: 2.5 in the control group,
2.2 in the intervention group, 2.4 in the "in-hospital" treatment
group
1-
9Randomized clinical trial of nutritional counseling
for malnourished hospital patientsCasals, 2015
Agreeement within working group, following attempt to
contact author1-
9Nutritional supplementation and dietary advice in
geriatric patients at risk of malnutrition.Persson, 2007 Confirmed by author 1+
9Post-discharge nutritional support in malnourished elderly individuals improves functional limitations
Neelemaat 2011 Confirmed by author 1++
9Oral nutritional support in malnourished elderly
decreases functional limitations with no extra costsNeelemaat 2012 a) Confirmed by author 1++
9Short-term oral nutritional intervention with protein and vitamin D decreases falls in malnourished older
adultsNeelemaat 2012 b) Confirmed by author 1++
9Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial
Deutz, 2016Mean Charlson comorbidity
index: 2.05 in the control group, 2.12 in the intervention group
1++
10Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment
Mendenhall, 1995> 2 co-occurring chronic diseases in > 50% of the study population
1-
10
Three month intervention with protein and energy rich supplements improve muscle function and
quality of life in malnourished patients with non-neoplastic gastrointestinal disease-A randomized
controlled trial.
Norman, 2008 Mean number of drugs: 6 in the
control group, 4 in the intervention group
1-
11Protein-Energy Undernutrition Among Elderly
Hospitalized PatientsSullivan, 1999 Confirmed by author 2++
11Positive effect of protein-supplemented hospital
food on protein intake in patients at nutritional risk: a randomised controlled trial
Munk, 2014Agreeement within working group, following attempt to
contact author1+
12Cost savings of an adult hospital nutrition support
teamKennedy, 2005 Confirmed by author 2+
12Positive effect of protein-supplemented hospital
food on protein intake in patients at nutritional risk: a randomised controlled trial
Munk, 2014Agreeement within working group, following attempt to
contact author1+
12Cost-effectiveness of an interdisciplinary
intervention in geriatric inpatients to prevent malnutrition
Rypkema, 2013Agreeement within working group, following attempt to
contact author2+